As professional skin care places greater emphasis on post-procedure retail continuity, the conversation is shifting from resurfacing intensity to recovery discipline.
The caliber of post-procedure care has been raised with the growing medspa movement and consumer awareness surrounding skin health, which makes perfect sense. Even the most diligent, who undergo a facial every two weeks, leave 14 days of home regimen to maintain or break results. For those who frequent medspas every six to eight weeks, that window increases the window of home care for which to support or diminish their aesthetic momentum.
Clients often leave treatment rooms with disrupted barrier function, heightened sensitivity and cumulative inflammatory stress. What's applied during this recovery window can either reinforce clinical outcomes or compromise them.
DERMA-CODE introduces its NAD+ PDRN 6 Peptide Facial Serum as a formulation engineered to restore visible calmness and barrier coherence during periods of increased skin demand.
Barrier disruption is common following chemical peels, microneedling, resurfacing procedures and high-active regimens. This product's formula contains 2% Sodium DNA (PDRN) within a defined 50–300 kDa molecular range to promote visible calmness and reinforce barrier stability under stress. To maintain hydration continuity and lipid reinforcement during treatment cycles, the serum integrates 6% squalane alongside 5% niacinamide.
Fragrance-free and color-free, the formulation remains intentionally minimal in aesthetic additives, allowing it to integrate into post-procedure protocols, maintenance regimens and high-active routines without escalating irritation.
For clinicians and estheticians, this creates a retail option that aligns home care with in-clinic treatment goals, while also remaining available for the professional backbar, as well as directly to consumers.
